There is no solid evidence that GLP-1 meds cause NAION, and the absolute risk if there even is one is so low it barely registers
Look Into Patient Assistance Programs If your income falls below certain thresholds, pharmaceutical manufacturers may provide medication at no cost through patient assistance programs (PAPs): Novo Nordisk PAP: Covers eligible uninsured patients or those on Medicare
Ultima tastes good too, but some flavors can be on the sweeter side
If gastrointestinal symptoms are severe, your healthcare provider may recommend delaying dose escalation or temporarily returning to a lower, previously tolerated dose of Zepbound, consistent with FDA-approved dosing guidance
Importantly, management commented that these providers are evenly distributed across the country further suggesting that the drug is gaining widespread rather than regional interest amongst BBS-treating physicians
Management of obesity in menopause